|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions |
ISO |
sirtinol inhibits the reaction [S-allylcysteine results in increased phosphorylation of ACACA protein] |
CTD |
PMID:23465592 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
AHR mutant form inhibits the reaction [sirtinol results in increased expression of CYP1A1 mRNA]; AHR mutant form inhibits the reaction [sirtinol results in increased expression of NQO1 mRNA] |
CTD |
PMID:22495798 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein]] |
CTD |
PMID:26450947 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
sirtinol inhibits the reaction [cilostazol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]] |
CTD |
PMID:24254769 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of BAX protein]] sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein]]; sirtinol promotes the reaction [cudraflavone B results in increased expression of BAX protein] |
CTD |
PMID:23881456 PMID:25665036 PMID:26450947 PMID:28851138 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]; sirtinol promotes the reaction [cudraflavone B results in decreased expression of BCL2 protein] |
CTD |
PMID:23881456 PMID:28851138 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
sirtinol inhibits the reaction [Resveratrol results in increased activity of CASP3 protein]; sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein]]; sirtinol promotes the reaction [cudraflavone B results in increased activity of CASP3 protein] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form]]; sirtinol promotes the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein modified form] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; sirtinol results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:20697895 PMID:23881456 PMID:24889822 PMID:25665036 PMID:26251326 PMID:26450947 PMID:28851138 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol results in increased activity of CASP9 protein] |
CTD |
PMID:20697895 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] |
CTD |
PMID:20531350 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
sirtinol results in increased expression of CCL20 mRNA |
CTD |
PMID:22385246 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Cd40 |
CD40 molecule |
multiple interactions |
ISO |
sirtinol promotes the reaction [TNF protein results in increased expression of CD40 mRNA] |
CTD |
PMID:22717288 |
|
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
sirtinol results in increased expression of CDKN1A mRNA; sirtinol results in increased expression of CDKN1A protein sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1A protein] |
CTD |
PMID:22495798 PMID:23881456 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein] |
CTD |
PMID:23881456 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Col10a1 |
collagen type X alpha 1 chain |
decreases expression |
ISO |
sirtinol results in decreased expression of COL10A1 protein |
CTD |
PMID:26251326 |
|
NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
sirtinol results in decreased expression of COL1A1 protein |
CTD |
PMID:26251326 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
decreases expression |
ISO |
sirtinol results in decreased expression of COL2A1 protein |
CTD |
PMID:26251326 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
increases expression |
EXP |
sirtinol results in increased expression of CYBA mRNA |
CTD |
PMID:23422569 |
|
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
sirtinol inhibits the reaction [rhodioloside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of CYBB protein]] |
CTD |
PMID:28851138 |
|
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO |
sirtinol results in increased expression of CYP1A1 mRNA AHR mutant form inhibits the reaction [sirtinol results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:22495798 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [cilostazol affects the expression of EP300 protein]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of EP300 protein]] |
CTD |
PMID:24254769 PMID:25665036 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions |
ISO |
sirtinol promotes the reaction [TNF protein results in increased expression of F3 mRNA]; sirtinol promotes the reaction [TNF protein results in increased expression of F3 protein] |
CTD |
PMID:20978007 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions |
ISO |
[sirtinol results in decreased activity of SIRT1 protein] which results in decreased expression of FBXO32 mRNA |
CTD |
PMID:22146233 |
|
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions increases acetylation |
ISO EXP |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased acetylation of FOXO1 protein]] sirtinol results in increased acetylation of FOXO1 protein sirtinol inhibits the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein]]; sirtinol promotes the reaction [Hydrogen Peroxide results in increased acetylation of FOXO1 protein] |
CTD |
PMID:24889822 PMID:25665036 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Gh1 |
growth hormone 1 |
multiple interactions increases secretion increases expression |
EXP |
sirtinol inhibits the reaction [resveratrol results in decreased secretion of GH1 protein] sirtinol results in increased secretion of GH1 protein sirtinol results in increased expression of GH1 mRNA |
CTD |
PMID:23292070 |
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
decreases expression |
ISO |
sirtinol results in decreased expression of IGF1R mRNA |
CTD |
PMID:22495798 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
increases expression |
ISO |
sirtinol results in increased expression of IGFBP3 mRNA |
CTD |
PMID:22495798 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [IL1B protein results in increased expression of CCL2 mRNA]] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]] sirtinol results in increased expression of IL1B mRNA |
CTD |
PMID:20531350 PMID:22385246 PMID:23973301 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Klf2 |
KLF transcription factor 2 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol results in increased expression of KLF2 mRNA] |
CTD |
PMID:19815564 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
decreases expression multiple interactions |
ISO |
sirtinol results in decreased expression of KLK3 mRNA; sirtinol results in decreased expression of KLK3 protein sirtinol inhibits the reaction [Estradiol results in increased expression of KLK3 mRNA] |
CTD |
PMID:22495798 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
sirtinol results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:21745208 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
sirtinol results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:21745208 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mir141 |
microRNA 141 |
multiple interactions |
EXP |
sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NOS1 protein]]; sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SNCA protein]] |
CTD |
PMID:33204711 |
|
NCBI chr 4:157,523,239...157,523,332
Ensembl chr 4:157,523,239...157,523,332
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
EXP |
sirtinol inhibits the reaction [resveratrol results in decreased expression of MYC protein] |
CTD |
PMID:24395567 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nanog |
Nanog homeobox |
multiple interactions |
ISO |
sirtinol inhibits the reaction [cordycepin results in increased expression of NANOG mRNA] |
CTD |
PMID:36881089 |
|
NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
sirtinol inhibits the reaction [resveratrol results in increased expression of NFE2L2 protein] |
CTD |
PMID:24395567 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
increases degradation |
ISO |
sirtinol results in increased degradation of NFKBIA protein |
CTD |
PMID:21745208 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nkx3-1 |
NK3 homeobox 1 |
decreases expression |
ISO |
sirtinol results in decreased expression of NKX3-1 mRNA |
CTD |
PMID:22495798 |
|
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
EXP |
sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NOS1 protein]] |
CTD |
PMID:33204711 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions increases expression |
EXP |
resveratrol inhibits the reaction [sirtinol results in increased expression of NOX4 mRNA] |
CTD |
PMID:23422569 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
ISO |
AHR mutant form inhibits the reaction [sirtinol results in increased expression of NQO1 mRNA] |
CTD |
PMID:22495798 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol results in increased expression of NR0B2 mRNA] |
CTD |
PMID:26044878 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
EXP |
sirtinol inhibits the reaction [resveratrol results in decreased expression of PDK1 protein] |
CTD |
PMID:24395567 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pdk4 |
pyruvate dehydrogenase kinase 4 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of PDK4 protein]] |
CTD |
PMID:26450947 |
|
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased expression of PDPK1 protein]] |
CTD |
PMID:26450947 |
|
NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [cordycepin results in increased expression of POU5F1 mRNA] |
CTD |
PMID:36881089 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO EXP |
sirtinol inhibits the reaction [Melatonin inhibits the reaction [Cadmium Chloride results in increased acetylation of PPARGC1A protein]]; sirtinol inhibits the reaction [Melatonin inhibits the reaction [Cadmium results in increased acetylation of PPARGC1A protein]] sirtinol inhibits the reaction [genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PPARGC1A protein]] sirtinol inhibits the reaction [resveratrol results in increased expression of PPARGC1A protein] |
CTD |
PMID:24395567 PMID:25159133 PMID:28477916 |
|
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
sirtinol inhibits the reaction [genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of PRKN protein]] |
CTD |
PMID:28477916 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]] |
CTD |
PMID:23257246 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
sirtinol promotes the reaction [cudraflavone B results in decreased phosphorylation of RB1 protein] |
CTD |
PMID:23881456 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions increases localization |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased acetylation of RELA protein]] sirtinol promotes the reaction [TNF protein results in increased acetylation of RELA protein] sirtinol results in increased localization of RELA protein |
CTD |
PMID:21745208 PMID:22717288 PMID:23257246 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Shc1 |
SHC adaptor protein 1 |
multiple interactions increases expression |
ISO |
sirtinol inhibits the reaction [SIRT1 protein binds to SHC1 promoter] sirtinol results in increased expression of SHC1 mRNA; sirtinol results in increased expression of SHC1 protein |
CTD |
PMID:21778425 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Sirt1 |
sirtuin 1 |
decreases activity multiple interactions |
ISO EXP |
sirtinol analog results in decreased activity of SIRT1 protein; sirtinol results in decreased activity of SIRT1 protein [sirtinol results in decreased activity of SIRT1 protein] promotes the reaction [Hydrogen Peroxide results in increased acetylation of TP53 protein]; [sirtinol results in decreased activity of SIRT1 protein] which results in decreased expression of FBXO32 mRNA; [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to Plant Extracts; [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to Resveratrol; [sirtinol results in decreased activity of SIRT1 protein] which results in increased susceptibility to Hydrogen Peroxide; sirtinol inhibits the reaction [[Resveratrol co-treated with TNF protein] results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [cordycepin results in increased expression of SIRT1 mRNA]; sirtinol inhibits the reaction [cudraflavone B results in increased expression of SIRT1 mRNA]; sirtinol inhibits the reaction [cudraflavone B results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [Melatonin inhibits the reaction [Cadmium Chloride results in decreased expression of and results in decreased activity of SIRT1 protein]]; sirtinol inhibits the reaction [Melatonin inhibits the reaction [Cadmium results in decreased expression of and results in decreased activity of SIRT1 protein]]; sirtinol inhibits the reaction [SIRT1 protein binds to SHC1 promoter] [sirtinol results in decreased activity of SIRT1 protein] which results in decreased susceptibility to Glucose; sirtinol inhibits the reaction [cilostazol inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of SIRT1 protein]]; sirtinol inhibits the reaction [cilostazol results in increased phosphorylation of SIRT1 protein]; sirtinol inhibits the reaction [genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of SIRT1 protein]]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased activity of SIRT1 protein]]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]] sirtinol inhibits the reaction [cobaltous chloride results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [Resveratrol results in increased expression of and results in increased activity of SIRT1 protein] |
CTD |
PMID:16302818 PMID:18681908 PMID:19288225 PMID:20370652 PMID:20531350 PMID:20610621 PMID:20697895 PMID:20978007 PMID:21745208 PMID:21778425 PMID:22146233 PMID:22385246 PMID:22563892 PMID:22669716 PMID:23257246 PMID:23315983 PMID:23479127 PMID:23881456 PMID:23973301 PMID:24254769 PMID:24395567 PMID:24998427 PMID:25159133 PMID:25665036 PMID:26450947 PMID:28477916 PMID:36881089 More...
|
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sirt2 |
sirtuin 2 |
decreases activity |
ISO |
sirtinol analog results in decreased activity of SIRT2 protein; sirtinol results in decreased activity of SIRT2 protein |
CTD |
PMID:16302818 PMID:24998427 |
|
NCBI chr 1:84,053,883...84,076,975
Ensembl chr 1:84,052,903...84,076,975
|
|
G |
Smad1 |
SMAD family member 1 |
decreases phosphorylation |
ISO |
sirtinol results in decreased phosphorylation of SMAD1 protein |
CTD |
PMID:21745208 |
|
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
|
|
G |
Smad5 |
SMAD family member 5 |
decreases phosphorylation |
ISO |
sirtinol results in decreased phosphorylation of SMAD5 protein |
CTD |
PMID:21745208 |
|
NCBI chr17:7,862,332...7,891,678
Ensembl chr17:7,864,720...7,891,634
|
|
G |
Smad9 |
SMAD family member 9 |
decreases phosphorylation |
ISO |
sirtinol results in decreased phosphorylation of SMAD9 protein |
CTD |
PMID:21745208 |
|
NCBI chr 2:138,956,326...139,006,315
Ensembl chr 2:138,986,471...139,006,307
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
EXP |
sirtinol affects the reaction [MIR141 mRNA affects the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SNCA protein]] |
CTD |
PMID:33204711 |
|
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [cordycepin results in increased expression of SOX2 mRNA] |
CTD |
PMID:36881089 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
EXP |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Hydrogen Peroxide results in increased expression of SQSTM1 protein]]; sirtinol promotes the reaction [Hydrogen Peroxide results in increased expression of SQSTM1 protein] |
CTD |
PMID:24889822 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [S-allylcysteine results in decreased expression of SREBF1 protein] |
CTD |
PMID:23465592 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
sirtinol inhibits the reaction [[resveratrol co-treated with TNF protein] results in increased expression of SIRT1 protein]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased acetylation of RELA protein]]; sirtinol inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]]; sirtinol promotes the reaction [TNF protein results in increased expression of F3 mRNA]; sirtinol promotes the reaction [TNF protein results in increased expression of F3 protein] Sirtinol promotes the reactions [Lipopolysaccharide, acetate, acetaldehyde increases secretion of Tnf protein from Kupffer cells] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; sirtinol promotes the reaction [TNF protein results in increased acetylation of RELA protein]; sirtinol promotes the reaction [TNF protein results in increased expression of CD40 mRNA] sirtinol results in increased expression of TNF mRNA |
CTD RGD |
PMID:20978007 PMID:22385246 PMID:22717288 PMID:23257246 PMID:23973301 PMID:19299582 More...
|
RGD:9585771 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[sirtinol results in decreased activity of SIRT1 protein] promotes the reaction [Hydrogen Peroxide results in increased acetylation of TP53 protein]; sirtinol promotes the reaction [arsenic disulfide results in increased expression of and results in increased phosphorylation of TP53 protein]; sirtinol promotes the reaction [cudraflavone B results in increased expression of TP53 protein] sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of TRP53 protein]] |
CTD |
PMID:18298901 PMID:18681908 PMID:23881456 PMID:25665036 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trim63 |
tripartite motif containing 63 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of TRIM63 protein]] |
CTD |
PMID:25665036 PMID:26450947 |
|
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
|
|
G |
Usp7 |
ubiquitin specific peptidase 7 |
multiple interactions |
ISO |
sirtinol inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of USP7 protein]] |
CTD |
PMID:25665036 |
|
NCBI chr10:6,880,684...6,925,355
Ensembl chr10:6,828,795...6,925,355
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
[sirtinol co-treated with cobaltous chloride] results in increased cleavage of VEGFA protein; sirtinol inhibits the reaction [cobaltous chloride results in increased secretion of VEGFA protein] |
CTD |
PMID:22669716 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|